Takeda Pharma to Buy Rare Disease Drugmaker Shire for $62 Billion

Takeda Pharma to Buy Rare Disease Drugmaker Shire for $62 Billion

By Carrie Ann - May 08, 2018

The Japanese company, Takeda Pharmaceutical will buy London-listed Shire Plc for $62.42 billion (46 billion pounds). The...

Read More